Azacitidine (Dr. Reddy’s Laboratories Inc.)
Welcome to the PulseAid listing for the Azacitidine drug offered from Dr. Reddy’s Laboratories Inc.. This Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Dr. Reddy’s Laboratories Inc. |
NON-PROPRIETARY NAME: | Azacitidine |
SUBSTANCE NAME: | AZACITIDINE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] |
ROUTE: | INTRAVENOUS; SUBCUTANEOUS |
DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2013-09-19 |
END MARKETING DATE: | 0000-00-00 |
Azacitidine HUMAN PRESCRIPTION DRUG Details:
Item Description | Azacitidine from Dr. Reddy’s Laboratories Inc. |
LABELER NAME: | Dr. Reddy’s Laboratories Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 100(mg/1) |
START MARKETING DATE: | 2013-09-19 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 43598-305_232e689b-eac0-961d-c96e-1497a5c33e9b |
PRODUCT NDC: | 43598-305 |
APPLICATION NUMBER: | ANDA201537 |
Other AZACITIDINE Pharmaceutical Manufacturers / Labelers: